Stockreport

Relmada Therapeutics Inc (RLMD) Q3 2024 Earnings Call Highlights: Navigating Financial ... [Yahoo! Finance]

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com
PDF Cash Used in Operations: $16.7 million for the third quarter ended September 30, 2024, compared to $11.6 million for the same period in 2023. Research and Development [Read more]